Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Xin Yi, PhD"'
Autor:
Song Dong, PhD, Bingfa Yan, PhD, Si-Yang Liu, PhD, Xuan Gao, PhD, Hui-Zhao Hong, MD, Hong-Ji Li, MD, Wei Gao, PhD, Hong-Hong Yan, PhD, Si-Yang Maggie Liu, PhD, Hai-Yan Tu, PhD, Yi Pan, PhD, Qing Zhou, PhD, Xue-Ning Yang, PhD, Xue-Feng Xia, PhD, Xin Yi, PhD, Wen-Zhao Zhong, PhD, Yi-Long Wu, MD, Jia-Tao Zhang, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 6, Iss 1, Pp 100758- (2025)
Introduction: EGFR tyrosine kinase inhibitor (TKI) is the standard adjuvant treatment for patients with stages IB to IIIA EGFR-mutated NSCLC. Nevertheless, adapting this approach to include a molecular residual disease (MRD)-guided de-escalation stra
Externí odkaz:
https://doaj.org/article/53643bd155c048d5bc49ea739a649af6
Autor:
Paloma del C. Monroig-Bosque MD, PhD, Jim W. Hsu MD, PhD, Michelle S. Lin MD, Ahmed N. Shehabeldin MD, John T. Rogers MD, Charlotte F. Kim MD, Ayaz G. Kalsekar MD, Zhicheng Jin PhD, Lukas R. Cara MD, Andreia N. Barbieri MD, Ziad El-Zaatari MD, Ghazaleh Eskandari MD, Tiffany G. Sheu MD, Jessica A. Tomsula MD, Scott W. Long MD, PhD, Arthur W. Zieske MD, Christopher M. Leveque MD, Eric Salazar MD, PhD, Dina R. Mody MD, Mary R. Schwartz MD, Matthew D. Cykowski MD, Xin Yi PhD, Suzanne Z. Powell MD, Jessica S. Thomas MD, PhD, MPH
Publikováno v:
Academic Pathology, Vol 7 (2020)
Pathology training programs throughout the United States have endured unprecedented challenges dealing with the ongoing coronavirus disease 2019 pandemic. At Houston Methodist Hospital, the Department of Pathology and Genomic Medicine planned and exe
Externí odkaz:
https://doaj.org/article/6c1e04ccfc5e4acebebc413f17bab497